Patents
Patents for C07C 307 - Amides of sulfuric acids, i.e. compounds having singly-bound oxygen atoms of sulfate groups replaced by nitrogen atoms, not being part of nitro or nitroso groups (1,726)
06/2009
06/09/2009US7544676 Sulfamoyl benzamides and methods of their use
05/2009
05/27/2009EP1519915B1 Tricyclic steroid hormone nuclear receptor modulators
05/27/2009CN100491336C Novel derivatives of 3,3-diphenylpropylamines
05/26/2009US7538241 Such as methyl 3,5-dihydroxy-2-phenylphenylacetate; antitumor activity; leukemia, multiple myeloma, lymphoma; heat shock protein 90 (Hsp90) suppression
05/13/2009EP2057117A2 Compounds for treating proliferative disorders
05/13/2009EP2057115A1 4-substituted phenoxyphenylacetic acid derivatives
04/2009
04/28/2009US7524969 Cardiovascular disorders; anticancer agents; antidiabetic agents; dietetics
04/23/2009WO2009050252A1 Novel sulfamate compounds for medical use
04/23/2009WO2009050120A1 Method for producing sulfonic acid diamides
04/23/2009US20090104126 Sulfamate Compounds and Uses Thereof
04/23/2009CA2700568A1 Novel sulfamate compounds for medical use
03/2009
03/31/2009US7511076 Deactivated proteins
03/31/2009CA2292549C Use of colchinol derivatives as vascular damaging agents
03/25/2009CN101395130A Acyclic sulfamide derivatives
03/25/2009CN101391759A Sulfamic acid production process
03/05/2009US20090062530 Substituted arylalkanoic acid derivatives and use thereof
02/2009
02/25/2009EP1143965B1 Carbocyclic potassium channel inhibitors
02/18/2009CN101367749A A set of mesidino mesitoyl derivant, preparation and application thereof
02/12/2009US20090042981 FDA Orange book listed patent for fesoterodine fumarate; urinary incontinence; isobutyric acid 2-(3-diisopropylamino-1-phenylpropyl)-4-hydroxymethylphenyl ester is fesoteridine
02/10/2009CA2386690C Pharmaceutical tramadol salts
01/2009
01/28/2009CN100455566C Novel derivatives of aminocyclohexane
01/22/2009US20090023801 Inhibitors of beta amyloid production
01/21/2009CN100453529C Aryl sulfonamides and analogues thereof and their use in treatment of neurodegenerative diseases
01/15/2009WO2009007696A1 Amino acid derivatives
01/15/2009CA2692608A1 Amino acid derivatives
01/14/2009EP1477472B1 Substituted phenylalkanoic acid derivative and use thereof
01/07/2009EP2010482A1 Coupling compounds and hair dyeing compositions containing them
12/2008
12/31/2008CA2690191A1 4-carboxybenzylamino derivatives as histone deacetylase inhibitors
12/30/2008US7470807 Suppress production of both prostaglandins and leukotrienes and have reduced side effects; treatment of various inflammatory diseases, autoimmune diseases, allergic diseases, pain and fibrosis; for example, methyl 3-[3-acetylamino-4-cyclopentyloxy-5-(naphthalen-2-yl)phenyl]propionate
12/23/2008US7468458 Accelerants for the modification of non-natural amino acids and non-natural amino acid polypeptides
12/23/2008US7468446 Substituted heterocyclic compounds and uses thereof
12/23/2008US7468174 Method for producing chlorosulfonyl isocyanate
12/18/2008WO2008109991A8 Inhibitors of carnitine palmitoyltransferase and treating cancer
12/18/2008US20080312313 Inhibitors of Ccr9 Activity
12/18/2008US20080312286 Indanone Potentiators of Metabotropic Glutamate Receptors
11/2008
11/27/2008WO2008024303A3 Compounds for treating proliferative disorders
11/27/2008US20080293727 Amine hydroxyalkyl sulfonamides as enzyme inhibitors; for example, N-1-(3-((3-acetylamino-4-fluoro-benzenesulfonyl)-benzyl-amino)-(1S,2 syn)-1-benzyl-2-hydroxy-propyl)-2-((quinoline-2-carbonyl)-amino)-succinamide; may be used as anti-viral agents against the HIV-1 and HIV-2 viruses
11/20/2008WO2008138639A1 Substituted phenylamino-benzene derivatives useful for treating hyper-proliferative disorders and diseases associated with mitogen extracellular kinase activity
11/20/2008CA2686484A1 Substituted phenylamino-benzene derivatives useful for treating hyper-proliferative disorders and diseases associated with mitogen extracellular kinase activity
11/06/2008US20080275221 Busulfan Immunoassay
11/06/2008US20080275114 Benzenesulfonamide derivatives; irritable bowel syndrome; may be co-administered with drug for inflammatory bowel disease; chemokine receptor inhibitors;
10/2008
10/29/2008EP1984326A1 Acyclic sulfamide derivatives
10/29/2008EP1984325A2 Sulfonanilide analogs as selective aromatase modulators
10/23/2008US20080261970 metabolic syndrome; diabetes; obesity; N-(2-(benzyloxy)-1-(6-methyl-[1,2,4]triazolo[4,3-a]pyridin-3-yl)ethyl)-1-methylpiperidine-4-sulfonamide
10/09/2008US20080249032 Derivatives of Arylsulfonamido-Substituted Hydroxamic Acid as Matrix Metalloproteinases Inhibitors
09/2008
09/23/2008US7427579 stabilizing the precursor particles of copper oxide, zinc oxide, and manganese oxide with a silica exhibits high selectivity, high yield, and high productivity
09/18/2008WO2008109991A1 Inhibitors of carnitine palmitoyltransferase and treating cancer
09/18/2008CA2680366A1 Inhibitors of carnitine palmitoyltransferase and treating cancer
09/09/2008US7423154 Asymmetric process for the preparation of diarylethylpiperazines derivatives and novel asymmetric diarylmethylamines as intermediates
09/04/2008US20080214870 Method of Preparing Amine Stereoisomers
08/2008
08/20/2008EP1957444A2 2,3,4,5-tetrahydroxy-6-sulfooxyhexanoic acid and its metal salts for medical use
08/19/2008US7414076 Methods and compositions for treating amyloid-related diseases
08/12/2008US7411072 e.g. 5-(10,11-Dihydro-dibenzo[a,d]cyclohepten-5-ylidenemethyl)-3H-benzooxazol-2-one; antiinflammatory, antidiabetic agent; electrolytes and water retention modulator; hypotensive, hypoglycemic agent; arrhythmias, myocardial fibrosis, osteoporosis, polyuria, polydipsia, Crohn's disease
08/06/2008EP1311475B1 Aminocyclohexane derivatives
08/05/2008CA2337098C Anthranilic acid derivatives
07/2008
07/30/2008EP1948631A2 Process for preparing mesylate salts of il-12 inhibitory compounds
07/23/2008EP1246797B1 Cyclopentyl sulfonamide derivatives
07/23/2008CN101225060A Method for synthesizing aliphatic amine polyoxyethylene ether ammonium sulfate
07/09/2008CN100400487C Glucocorticoid receptor modulators
07/03/2008DE10249321B4 Verfahren zur Herstellung von Cyclohexanonen Process for the preparation of cyclohexanones
06/2008
06/10/2008US7385063 Method for preparing imidazole derivatives
06/10/2008US7384980 Derivatives of 3,3-diphenylpropylamines
06/04/2008EP1193250B1 Phenyl sulfamate derivatives
05/2008
05/14/2008EP1919861A2 Compounds for treating alzheimer's disease
05/14/2008CN100387576C Substituted phenylalkanoic acid derivatives and use thereof
05/07/2008CN100386311C Method for producing chlorosulfonyl isocyanate
05/06/2008CA2377803C Phenyl sulfamate derivatives
04/2008
04/30/2008EP1915339A1 Beta-secretase inhibitors for use in the treatment of alzheimer's disease
04/29/2008US7365223 Method for selective targeting of apoptotic cells and small molecule ligands used thereof
04/24/2008US20080096922 N-{[cis-1-(3-methoxyphenyl)-4-(piperidin-4-ylamino)-cyclohexyl]methyl}sulfamide diHCL; tert-butyl [({[cis-4-[(biphenyl-4-ylmethyl)amino]-1-(3-methoxyphenyl)cyclohexyl]methyl}amino)sulfonyl]carbamate; for potentiating expression of low density lipoprotein recepotr; arteriosclerosis; hyperlipidemia
04/24/2008US20080093582 sulfonate or sulfate derivatives or modified polyethers for improving solubility to dissolve polar compound in subcritical liquid carbon dioxide; wastewater treatment; improve the function of carbon dioxide as solvent for chemical reactions, washing, extraction, dyeing
04/16/2008CN101161641A Tricyclic steroid hormone nuclear receptor modulators
04/15/2008CA2328920C Novel derivatives of 3,3-diphenylpropylamines
04/15/2008CA2319092C Anionic surfactants based on alkene sulfonic acid
04/09/2008EP0958287B2 Sulfamide-metalloprotease inhibitors
04/01/2008CA2218434C Fluorinated ionic sulfonylmethylides and sulfonylimides, preparation process and use as photoinitiators
03/2008
03/27/2008US20080076667 Substituted fluoroalkoxyphenylsulfonylureas
03/26/2008CN100376242C 2-aryl-propionic acid and medicine composition containing same
03/20/2008WO2007120379A3 Sulfonanilide analogs as selective aromatase modulators
03/20/2008US20080070869 Malonyl-CoA Decarboxylase Inhibitors Useful as Metabolic Modulators
03/20/2008US20080069851 Substituted n-aminomethylene sulfonamides, production and use thereof as medicaments
03/18/2008US7345202 Use of sulfamic acids as resolving agent
03/12/2008EP1896401A2 Unsaturated sulfides, sulfones, sulfoxides and sulfonamides synthesis
03/06/2008US20080058302 Sulfamoyl Benzamides and Methods of Their Use
03/04/2008US7338958 Sulfoximine-substituted pyrimidines as CDK-and/or VEGF inhibitors, their production and use as pharmaceutical agents
02/2008
02/28/2008WO2008024746A1 4-substituted phenoxyphenylacetic acid derivatives
02/28/2008WO2008024303A2 Compounds for treating proliferative disorders
02/28/2008CA2661164A1 4-substituted phenoxyphenylacetic acid derivatives
02/28/2008CA2660524A1 Compounds for treating proliferative disorders
02/27/2008EP1695958B1 Method for producing chlorosulfonyl isocyanate
02/26/2008US7335687 Used to treat hypercholesterolemia, hyperlipemia, arteriosclerosis, mycoses, gallstones, hyperproliferative disorders, impaired glucose tolerance, or diabetes; aminocyclohexanol derivatives; e.g. N-(4-(4-[ethyl-(2-hydroxy-ethyl)-amino]-but-1-ynyl)-cyclohexyl)-N-methyl-4-trifluoromethyl-benzenesulfonamide
02/26/2008US7335686 Method and composition for treating osteoporosis
02/19/2008US7332610 Chemical intermediates for production of sibutramine
02/14/2008US20080039654 Polyoxyalkylene ammonium salts and their use as antistatic agents
02/13/2008CN100368392C Bifunctional phenyliso(thio)cyanates, processes and intermediates products for their preparation
02/12/2008CA2280270C Acrylonitrile compounds, process for their production and pesticides containing them
02/07/2008US20080033174 Method for the Production of 3-Phenyl (Thio) Uracils and Dithiouracils
01/2008
01/30/2008EP1881959A1 Process for preparation of sulfamide derivatives
01/29/2008US7323596 Antibacterial or antiprotozoal activity: formula (1) formula (2) wherein: Z represents a radical of formula N(OH)CH( .dbd. O) or of formula C( .dbd. O)NH(OH); R1 represents hydrogen, methyl or trifluoromethyl, or, except when Z is a radical of
01/17/2008WO2008007780A1 Pentadienamide derivative
1 2 3 4 5 6 7 8 9 10 11 12 13 14 ... 18